Aligos Therapeutics Inc (ALGS)

12.12 -0.57  -4.49% NASDAQ Dec 7, 16:00 12.12 0.00  0.00% After-Hours: 19:33 USD

Aligos Therapeutics Cash from Investing (TTM):

34.44M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 34.44M
June 30, 2021 61.13M
March 31, 2021 66.22M
Dec. 31, 2020 32.76M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

CEL-SCI Corp -20.90M
AIM ImmunoTech Inc -1.177M
NovaBay Pharmaceuticals Inc -0.065M

Cash from Investing (TTM) Range, Past 5 Years

Minimum 32.76M Dec 2020
Maximum 66.22M Mar 2021
Average 48.64M





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.